{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:28:54Z","timestamp":1792412934906,"version":"4.4.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-022-05166-5","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T11:02:51Z","timestamp":1658142171000},"page":"1849-1854","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Methotrexate induced neurotoxicity in a patient with rheumatoid arthritis on rituximab therapy: a case-based review"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5275-8639","authenticated-orcid":false,"given":"Nikolaos","family":"Kougkas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasia","family":"Dara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5755-1538","authenticated-orcid":false,"given":"Eleni","family":"Pagkopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Androniki","family":"Dimitriadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evdokia","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Avdelidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7289-1293","authenticated-orcid":false,"given":"Alexandros","family":"Garyfallos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0364-1642","authenticated-orcid":false,"given":"Theodoros","family":"Dimitroulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"issue":"Suppl 1","key":"5166_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.31138\/mjr.31.1.163","volume":"31","author":"D Vassilopoulos","year":"2020","unstructured":"Vassilopoulos D, Aslanidis S, Boumpas D et al (2020) Updated Greek rheumatology society guidelines for the management of rheumatoid arthritis. Mediterr J Rheumatol 31(Suppl 1):163","journal-title":"Mediterr J Rheumatol"},{"key":"5166_CR2","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1136\/ard.2008.092668","volume":"68","author":"K Visser","year":"2009","unstructured":"Visser K, van der Heijde D (2009) Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature. Ann Rheum Dis 68:1094\u20131099","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5166_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.31138\/mjr.28.2.75","volume":"28","author":"LI Sakkas","year":"2017","unstructured":"Sakkas LI (2017) Regulatory B cells in autoimmune rheumatic diseases. Mediterr J Rheumatol 28(2):75\u201379","journal-title":"Mediterr J Rheumatol"},{"issue":"11","key":"5166_CR4","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00296-010-1526-y","volume":"31","author":"YH Lee","year":"2011","unstructured":"Lee YH, Bae SC, Song GG (2011) The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials. Rheumatol Int 31(11):1493\u20131499. https:\/\/doi.org\/10.1007\/s00296-010-1526-y","journal-title":"Rheumatol Int"},{"issue":"4","key":"5166_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/17843286.2018.1521904","volume":"74","author":"N Berghen","year":"2019","unstructured":"Berghen N, Vulsteke JB, Westhovens R, Lenaerts J, de Langhe E (2019) Rituximab in systemic autoimmune rheumatic diseases: indications and practical use. Acta Clin Belg 74(4):272\u2013279. https:\/\/doi.org\/10.1080\/17843286.2018.1521904","journal-title":"Acta Clin Belg"},{"issue":"Suppl 1","key":"5166_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.31138\/mjr.31.1.129","volume":"31","author":"K Thomas","year":"2020","unstructured":"Thomas K, Vassilopoulos D (2020) Infections in patients with rheumatoid arthritis in the era of targeted synthetic therapies. Mediterr J Rheumatol 31(Suppl 1):129\u2013136","journal-title":"Mediterr J Rheumatol"},{"issue":"3","key":"5166_CR7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s13365-018-0615-7","volume":"24","author":"JR Berger","year":"2018","unstructured":"Berger JR, Malik V, Lacey S, Brunetta P, Lehane PB (2018) Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event. J Neurovirol 24(3):323\u2013331. https:\/\/doi.org\/10.1007\/s13365-018-0615-7","journal-title":"J Neurovirol"},{"issue":"9","key":"5166_CR8","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1001\/archneurol.2011.103","volume":"68","author":"DB Clifford","year":"2011","unstructured":"Clifford DB (2011) Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol 68(9):1156. https:\/\/doi.org\/10.1001\/archneurol.2011.103","journal-title":"Arch Neurol"},{"key":"5166_CR9","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H et al (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"issue":"9","key":"5166_CR10","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3899\/jrheum.120152","volume":"39","author":"H Koppen","year":"2012","unstructured":"Koppen H, Wessels JA, Ewals JAPM, Treurniet FEE (2012) Reversible leukoencephalopathy after oral methotrexate: figure 1. J Rheumatol 39(9):1906\u20131907","journal-title":"J Rheumatol"},{"issue":"1","key":"5166_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12311-013-0528-1","volume":"13","author":"I Gonz\u00e1lez-Su\u00e1rez","year":"2014","unstructured":"Gonz\u00e1lez-Su\u00e1rez I, Aguilar-Amat MJ, Trigueros M, Borobia AM, Cruz A, Arpa J (2014) Leukoencephalopathy due to oral methotrexate. Cerebellum 13(1):178\u2013183. https:\/\/doi.org\/10.1007\/s12311-013-0528-1","journal-title":"Cerebellum"},{"issue":"5","key":"5166_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/mpo.2950160502","volume":"16","author":"M Abromowitch","year":"1988","unstructured":"Abromowitch M, Ochs J, Pui CH et al (1988) High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude total therapy study X. Med Pediatr Oncol 16(5):297\u2013303","journal-title":"Med Pediatr Oncol"},{"issue":"1","key":"5166_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/1097-0142(19820701)50:1%3C42::AID-CNCR2820500109%3E3.0.CO;2-M","volume":"50","author":"AW Clark","year":"1982","unstructured":"Clark AW, Cohen SR, Nissenblatt MJ, Wilson SK (1982) Paraplegia following intrathecal chemotherapy neuropathologic findings and elevation of myelin basic protein. Cancer 50(1):42\u201347. https:\/\/doi.org\/10.1002\/1097-0142(19820701)50:1%3C42::AID-CNCR2820500109%3E3.0.CO;2-M","journal-title":"Cancer"},{"issue":"4","key":"5166_CR14","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1200\/JCO.1998.16.4.1505","volume":"16","author":"R Surtees","year":"1998","unstructured":"Surtees R, Clelland J, Hann I (1998) Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies. J Clin Oncol 16(4):1505\u20131511. https:\/\/doi.org\/10.1200\/JCO.1998.16.4.1505","journal-title":"J Clin Oncol"},{"issue":"1","key":"5166_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41927-020-00175-y","volume":"5","author":"MA Jara-Palacios","year":"2021","unstructured":"Jara-Palacios MA, Chun W, Traub NL (2021) Potential contributors to low dose methotrexate toxicity in a patient with rheumatoid arthritis and pernicious anemia: case report. BMC Rheumatol 5(1):5. https:\/\/doi.org\/10.1186\/s41927-020-00175-y","journal-title":"BMC Rheumatol"},{"issue":"19","key":"5166_CR16","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.2169\/internalmedicine.50.5552","volume":"50","author":"M Matsuda","year":"2011","unstructured":"Matsuda M, Kishida D, Kinoshita T et al (2011) Leukoencephalopathy Induced by low-dose methotrexate in a patient with rheumatoid arthritis. Intern Med 50(19):2219\u20132222. https:\/\/doi.org\/10.2169\/internalmedicine.50.5552","journal-title":"Intern Med"},{"issue":"4","key":"5166_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00401-007-0214-9","volume":"114","author":"H Yokoo","year":"2007","unstructured":"Yokoo H, Nakazato Y, Harigaya Y, Sasaki N, Igeta Y, Itoh H (2007) Massive myelinolytic leukoencephalopathy in a patient medicated with low-dose oral methotrexate for rheumatoid arthritis: an autopsy report. Acta Neuropathol 114(4):425\u2013430. https:\/\/doi.org\/10.1007\/s00401-007-0214-9","journal-title":"Acta Neuropathol"},{"issue":"3","key":"5166_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1468-1331.2006.01659.x","volume":"14","author":"S Raghavendra","year":"2007","unstructured":"Raghavendra S, Nair MD, Chemmanam T, Krishnamoorthy T, Radhakrishnan V, v., Kuruvilla A. (2007) Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate. Eur J Neurol 14(3):309\u2013314","journal-title":"Eur J Neurol"},{"key":"5166_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2077","author":"D Focosi","year":"2019","unstructured":"Focosi D, Tuccori M, Maggi F (2019) Progressive multifocal leukoencephalopathy and anti-CD20 monoclonal antibodies: What do we know after 20 years of rituximab. Rev Med Virol. https:\/\/doi.org\/10.1002\/rmv.2077","journal-title":"Rev Med Virol"},{"key":"5166_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16563","author":"F D\u2019Al\u00f2","year":"2020","unstructured":"D\u2019Al\u00f2 F, Malafronte R, Piludu F et al (2020) Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance. Br J Haematol. https:\/\/doi.org\/10.1111\/bjh.16563","journal-title":"Br J Haematol"},{"issue":"1","key":"5166_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1148\/radiology.187.1.8451420","volume":"187","author":"ML Whiteman","year":"1993","unstructured":"Whiteman ML, Post MJ, Berger JR, Tate LG, Bell MD, Limonte LP (1993) Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiol 187(1):233\u2013240. https:\/\/doi.org\/10.1148\/radiology.187.1.8451420","journal-title":"Radiol"},{"issue":"9","key":"5166_CR22","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3174\/ajnr.A2035","volume":"31","author":"AK Bag","year":"2010","unstructured":"Bag AK, Cur\u00e9 JK, Chapman PR, Roberson GH, Shah R (2010) JC Virus Infection of the Brain. Am J Neuroradiol 31(9):1564\u20131576. https:\/\/doi.org\/10.3174\/ajnr.A2035","journal-title":"Am J Neuroradiol"},{"issue":"15","key":"5166_CR23","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","volume":"80","author":"JR Berger","year":"2013","unstructured":"Berger JR, Aksamit AJ, Clifford DB et al (2013) PML diagnostic criteria. Neurol 80(15):1430\u20131438. https:\/\/doi.org\/10.1212\/WNL.0b013e31828c2fa1","journal-title":"Neurol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05166-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-022-05166-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05166-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T06:05:45Z","timestamp":1662098745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-022-05166-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["5166"],"URL":"https:\/\/doi.org\/10.1007\/s00296-022-05166-5","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"assertion":[{"value":"19 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from this patient for publication of the case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}